Browse by category

Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression

Tetra Pharm Technologies has reached a significant in developing its compound for appetite suppression, TPT0701, following the successful...

Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays

3 hours ago

Journal Watch 18/12/2024

6 hours ago

True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation

7 hours ago

Weekly Digest